2012
DOI: 10.1371/4f972cffe82c0
|View full text |Cite
|
Sign up to set email alerts
|

A mixed fixed ratio/progressive ratio procedure reveals an apathy phenotype in the BAC HD and the z_Q175 KI mouse models of Huntington’s disease

Abstract: Apathy, characterized by generally reduced interest in and likelihood to perform goal-directed actions, is a recognized symptom of Huntington’s disease (HD), a devastating neurological disorder caused by a CAG repeat expansion of the Htt gene located on chromosome 4. The present experiments used a modified progressive ratio task that incorporated a fixed-ratio schedule of reinforcement component to assess consummatory behavior, and a progressive-ratio schedule component that required increasing numbers of leve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
31
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 29 publications
(36 citation statements)
references
References 21 publications
5
31
0
Order By: Relevance
“…Furthermore, this system could be used to estimate a drug's ability to rescue a disease phenotype while assessing its side effects 10 , or to discover new and unexpected animal model phenotypes 30 . One limitation of the approach is that it excludes tests of higher cognitive functions (e.g., learning and memory) that require training in multiple sessions over time but may be important for translation to the clinic 31 .…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, this system could be used to estimate a drug's ability to rescue a disease phenotype while assessing its side effects 10 , or to discover new and unexpected animal model phenotypes 30 . One limitation of the approach is that it excludes tests of higher cognitive functions (e.g., learning and memory) that require training in multiple sessions over time but may be important for translation to the clinic 31 .…”
Section: Discussionmentioning
confidence: 99%
“…This term is most frequently used to refer to motivational deficits in schizophrenia, dysthymia, depression, stroke, progressive supranuclear palsy, and neurodegeneration, particularly in Huntington’s disease (Ishizaki and Mimura, 2011; van Reekum et al, 2005). Apathy is defined as “diminished goal-oriented behavior and cognition, and a diminished emotional connection to goal-directed behavior” (Marin, 1991); thus, this term describes a type of motivational dysfunction relevant to the focus of this review (Clarke et al, 2011; Oakeshott et al, 2012). …”
Section: Clinical and Preclinical Terminologymentioning
confidence: 99%
“…These activational aspects of motivation are widely studied in behavioral neuroscience, and they are clinically relevant also. As discussed above, clinicians have come to emphasize the importance of motivational symptoms related to effort expenditure, such as psychomotor slowing, apathy, and anergia in major depression, fatigue in parkinsonism and multiple sclerosis, and avolition in schizophrenia (Demyttenaere et al, 2005; Oakeshott et al, 2012; Salamone et al, 2006, 2010; Ward et al, 2011; Treadway and Zald, 2011). Moreover, it has been argued that many people with psychopathologies have fundamental deficits in reward seeking, exertion of effort, and effort-related decision making that do not simply depend on any problems that they may have with experiencing pleasure (Treadway and Zald, 2011).…”
Section: Tasks That Assess the Construct Of Motivationmentioning
confidence: 99%
“…The protocol for this test has been described in our initial study of the BACHD rats’ food consumption rates [18], and similar protocols have been described by others [2833]. The aim of the test is to acquire a basic measurement of the rats’ apparent interest in food, i.e.…”
Section: Methodsmentioning
confidence: 99%